stockrowQuest Diagnostics Incorporated (DGX) vs Revvity Inc. (RVTY)
- Quest Diagnostics Incorporated DGX 254.25 −0.56%
- Revvity Inc. RVTY 150.97 −5.31%
Quest Diagnostics Incorporated and Revvity Inc. are both Diagnostics & Research companies. Quest Diagnostics Incorporated is the larger, with a market value of $28.0B against $16.8B — 1.7× the size. Quest Diagnostics Incorporated trades at the lower P/E: 25.0× against 71.9×. Quest Diagnostics Incorporated grew revenue faster over the last twelve months: 9.13% against 4.56%. Quest Diagnostics Incorporated has the higher net margin (9.50% vs 8.61%) and the higher return on invested capital (8.48% vs 2.50%). Both pay a dividend; Quest Diagnostics Incorporated yields more (1.33% vs 0.19%). Across the 23 metrics below, Quest Diagnostics Incorporated leads on 18 and Revvity Inc. on 5.
Valuation
Profitability
| Metric | DGX | RVTY | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 33.11% | 55.91% | 48.32% |
| Operating margin | 14.55% | 12.65% | (5.68%) |
| Net margin | 9.50% | 8.61% | (4.10%) |
| Free cash flow margin | 11.61% | 20.48% | 0.00% |
| Return on equity | 14.76% | 0.00% | 0.00% |
| Return on assets | 6.73% | 2.14% | (6.05%) |
| Return on invested capital | 8.48% | 2.50% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack